デフォルト表紙
市場調査レポート
商品コード
1427957

医薬品連続製造の世界市場レポート 2024年

Pharmaceutical Continuous Manufacturing Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医薬品連続製造の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

医薬品連続製造の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.4%の年間複合成長率(CAGR)で37億1,000万米ドルに成長すると予想されます。予測期間の成長は、ジェネリック医薬品生産の増加、バイオ医薬品製造、個別化医薬品製造、患者中心のアプローチへの注力によるものと考えられます。予測期間の主要動向には、連続製造の採用、プロセス分析技術の統合、高度な自動化とロボティクスの使用、戦略的コラボレーションとパートナーシップ、デジタル化と接続性が含まれます。

医薬品連続製造市場で予想される成長は、いくつかの重要な要因によって促進されると予想されます。第一に、慢性疾患の有病率の増加が重要な促進要因となる可能性があります。 1年以上持続し、継続的な治療を必要とする慢性疾患は、世界的にますます蔓延しています。 医薬品連続製造プロセスは、医薬品生産への合理化されたアプローチを提供し、効率を高めてコストを削減します。このアプローチは、長期の薬物使用を必要とする慢性疾患の管理に特に有利です。たとえば、全米慢性疾患ディレクター協会の報告書は、成人アメリカ人のほぼ60%が少なくとも1つの慢性疾患を患っており、約40%が複数の慢性疾患を抱えていることを強調しています。これらの状況による経済的影響は、2030年までに米国で年間2兆米ドルに達すると予想されています。したがって、慢性疾患の蔓延に応じて、医薬品連続製造の需要が高まる可能性があります。

産業オートメーションの急増は、医薬品連続製造市場の成長に大きく貢献すると予想されます。産業オートメーションには、コンピューターやロボットなどの制御システムを使用して、産業内のさまざまなプロセスや機械を管理し、人間の介入を削減または置き換えることが含まれます。 医薬品連続製造のコンテキストでは、産業オートメーションはリアルタイムの監視とフィードバック制御を促進し、人的エラーを最小限に抑え、一貫した製品品質を保証します。国際ロボット連盟の報告によると、世界中で新しい産業用ロボットの設置が顕著に増加しており、自動化への傾向が高まっていることを示しています。 2021年の前年比成長率は31%で、全世界で合計約350万台の稼働ロボットが存在することから、産業オートメーションは医薬品連続製造市場の成長の原動力であることが証明されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の医薬品連続製造市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の医薬品連続製造市場規模実績と成長、2018~2023年
  • 世界の医薬品連続製造市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の医薬品連続製造市場、製品別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 統合連続システム
  • 制御とソフトウェア
  • 半連続システム
  • 世界の医薬品連続製造市場、治療薬タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 高分子
  • 低分子
  • 世界の医薬品連続製造市場、製剤別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 固形製剤
  • 液体と半固体製剤
  • 世界の医薬品連続製造市場、用途別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 最終医薬品の製造
  • 医薬品原薬(API)の製造
  • 世界の医薬品連続製造市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 製薬会社
  • 受託製造組織
  • その他

第7章 地域と国の分析

  • 世界の医薬品連続製造市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の医薬品連続製造市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医薬品連続製造市場の競合情勢
  • 医薬品連続製造市場の企業プロファイル
    • Pfizer Inc.
    • Robert Bosch GmbH
    • Siemens AG
    • Novartis AG
    • Thermo Fisher Scientific Inc.

第31章 その他の大手と革新的な企業

  • GlaxoSmithKline Plc.
  • Eli Lilly and Company
  • Corning Inc.
  • Vertex Pharmaceuticals
  • Lonza Group Ltd.
  • GEA Group AG
  • Catalent Inc.
  • Mettler Toledo
  • Patheon
  • Cytiva
  • Samsung Biologics Co. Ltd.
  • WuXi Biologics
  • Syntegon Technology GmbH
  • Coperion GmbH
  • Hosokawa Micron Group

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13801

Pharmaceutical continuous manufacturing (PCM) is a streamlined process that involves the production of pharmaceutical goods from initiation to completion on a single, uninterrupted production line. This innovative approach is particularly utilized for manufacturing active pharmaceutical components through continuous flow chemical transformations and multistep syntheses, allowing for extended operational durations and potentially mitigating medicine shortages.

The primary categories of pharmaceutical continuous manufacturing products include integrated continuous systems, controls and software, and semi-continuous systems. The Integrated Continuous System (ICS) represents a comprehensive method for producing pharmaceutical items seamlessly on a continuous production line. These systems find application in the manufacturing of both large molecule and small molecule therapeutics, playing a vital role in producing solid formulations, liquids, and semi-solid formulations. ICS is deployed in various applications, including final drug product manufacturing and active pharmaceutical ingredient (API) manufacturing. This technology is adopted by diverse end-users such as pharmaceutical companies, contract manufacturing organizations, and other relevant entities in the pharmaceutical industry.

The pharmaceutical continuous manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical continuous manufacturing market statistics, including pharmaceutical continuous manufacturing industry global market size, regional shares, competitors with a pharmaceutical continuous manufacturing market share, detailed pharmaceutical continuous manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical continuous manufacturing industry. This pharmaceutical continuous manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical continuous manufacturing market size has grown rapidly in recent years. It will grow from $2.26 billion in 2023 to $2.5 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%.The growth observed in the historic period can be credited to several key factors. Quality and efficiency improvements played a significant role, enhancing the overall performance of processes. The reduction in time-to-market for pharmaceutical products contributed to quicker availability and responsiveness to market needs. Cost reduction and operational efficiency measures were implemented, optimizing resource utilization and enhancing the financial viability of pharmaceutical operations. Regulatory support and adherence to guidelines ensured compliance and streamlined approval processes. The incorporation of flexibility and scalability in operations allowed for adaptability to changing market dynamics and varying production demands, contributing to sustained growth in the pharmaceutical industry.

The pharmaceutical continuous manufacturing market size is expected to see rapid growth in the next few years. It will grow to $3.71 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing generic drug production, biopharmaceutical manufacturing, personalized medicine manufacturing, focus on patient-centric approaches. Major trends in the forecast period include adoption of continuous manufacturing, integration of process analytical technology, use of advanced automation and robotics, strategic collaborations and partnerships, digitalization and connectivity.

The anticipated growth in the pharmaceutical continuous manufacturing market is expected to be driven by several key factors. Firstly, the increasing prevalence of chronic ailments is poised to be a significant driver. Chronic diseases, persisting for a year or longer and requiring ongoing medical treatment, are becoming more prevalent globally. Pharmaceutical continuous manufacturing processes offer a streamlined approach to drug production, enhancing efficiency and reducing costs. This approach is particularly advantageous for managing chronic conditions that necessitate long-term medication use. For example, a report by the National Association of Chronic Disease Directors highlighted that nearly 60% of adult Americans have at least one chronic disease, with around 40% having multiple chronic conditions. The economic impact of these conditions is expected to reach $2 trillion annually in the United States by 2030. Thus, the demand for pharmaceutical continuous manufacturing is likely to rise in response to the growing prevalence of chronic ailments.

The surge in industrial automation is expected to contribute significantly to the growth of the pharmaceutical continuous manufacturing market. Industrial automation involves the use of control systems, such as computers or robots, to manage various processes and machinery in industries, reducing or replacing human intervention. In the context of pharmaceutical continuous manufacturing, industrial automation facilitates real-time monitoring and feedback control, minimizing human error and ensuring consistent product quality. The notable increase in the installation of new industrial robots worldwide, as reported by the International Federation of Robotics, indicates a growing trend towards automation. With a year-on-year growth rate of 31% in 2021 and a total of approximately 3.5 million operational robots globally, industrial automation is proving to be a driving force behind the growth of the pharmaceutical continuous manufacturing market.

Technological innovations are emerging as a prominent trend in the pharmaceutical continuous manufacturing market, with major companies actively developing new products to maintain their market positions. One notable example is the introduction of the USP Advanced Manufacturing Technology Lab by The United States Pharmacopeia (USP) in December 2022. This initiative includes the launch of R&D analytical solutions aimed at assisting drug manufacturers in adopting advanced manufacturing technologies, such as pharmaceutical continuous manufacturing (PCM). The goal is to enhance geographic diversity in pharmaceutical manufacturing, thereby bolstering the resilience of the medicine supply chain. The lab services provided by USP facilitate the characterization of materials and the development and qualification of methods to ensure the quality of PCM-based medications.

Major companies in the pharmaceutical continuous manufacturing market are focusing on the development of advanced equipment, such as continuous manufacturing lines, to gain a competitive edge. For instance, WuXi STA, a China-based contract research development, and manufacturing organization (CRDMO), launched a Continuous Manufacturing (CM) line for oral solids in January 2023. This CM line, compliant with global cGMP regulations, introduces advancements in oral drug development by incorporating continuous direct compression equipment for various processes, including dispensing, blending, lubrication, tablet compression, and coating. Process Analytical Technology (PAT) is integrated into the system to monitor blending uniformity in real-time, ensuring high product quality.

In January 2023, Cambrex Corporation, a US-based contract development manufacturing organization (CDMO) for pharmaceuticals, acquired Snapdragon Chemistry Inc. This acquisition strengthened Cambrex's expertise in active pharmaceutical ingredient (API) process development in continuous flow manufacturing. Snapdragon Chemistry Inc., a US-based company specializing in API batch and continuous flow process development, was integrated to complement Cambrex's recent investments in endless flow process development capabilities. These initiatives collectively showcase the industry's commitment to leveraging technological innovations for advancements in pharmaceutical continuous manufacturing.

Major companies operating in the pharmaceutical continuous manufacturing market report are Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRUDER LODIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV

Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical continuous manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical continuous manufacturing market consists of revenues earned by entities by providing manufacturing services such as mixing, granulation, coating, and tablet compression. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical continuous manufacturing market also includes sales of organic PCM and inorganic PCM techniques. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Continuous Manufacturing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical continuous manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical continuous manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical continuous manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Integrated Continuous System; Control And Software; Semi-Continuous System
  • 2) By Therapeutics Type: Large Molecule; Small Molecule
  • 3) By Formulation: Solid Formation; Liquid And Semi-Solid Formation
  • 4) By Application: Final Drug Product Manufacturing; Active Pharmaceutical Ingredient (API) Manufacturing
  • 5) By End-Users: Pharmaceutical Companies; Contract Manufacturing Organization; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Robert Bosch GmbH; Siemens AG; Novartis AG; Thermo Fisher Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Continuous Manufacturing Market Characteristics

3. Pharmaceutical Continuous Manufacturing Market Trends And Strategies

4. Pharmaceutical Continuous Manufacturing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Continuous Manufacturing Market Size and Growth

  • 5.1. Global Pharmaceutical Continuous Manufacturing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmaceutical Continuous Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmaceutical Continuous Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Continuous Manufacturing Market Segmentation

  • 6.1. Global Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Integrated Continuous System
  • Control And Software
  • Semi-Continuous System
  • 6.2. Global Pharmaceutical Continuous Manufacturing Market, Segmentation By Therapeutics Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Large Molecule
  • Small Molecule
  • 6.3. Global Pharmaceutical Continuous Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Solid Formulation
  • Liquid And Semi-Solid Formulation
  • 6.4. Global Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Final Drug Product Manufacturing
  • Active Pharmaceutical Ingredient (API) Manufacturing
  • 6.5. Global Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Contract Manufacturing Organization
  • Other End-Users

7. Pharmaceutical Continuous Manufacturing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Continuous Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmaceutical Continuous Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Continuous Manufacturing Market

  • 8.1. Asia-Pacific Pharmaceutical Continuous Manufacturing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Continuous Manufacturing Market

  • 9.1. China Pharmaceutical Continuous Manufacturing Market Overview
  • 9.2. China Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Continuous Manufacturing Market

  • 10.1. India Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Continuous Manufacturing Market

  • 11.1. Japan Pharmaceutical Continuous Manufacturing Market Overview
  • 11.2. Japan Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Continuous Manufacturing Market

  • 12.1. Australia Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Continuous Manufacturing Market

  • 13.1. Indonesia Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Continuous Manufacturing Market

  • 14.1. South Korea Pharmaceutical Continuous Manufacturing Market Overview
  • 14.2. South Korea Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Continuous Manufacturing Market

  • 15.1. Western Europe Pharmaceutical Continuous Manufacturing Market Overview
  • 15.2. Western Europe Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Continuous Manufacturing Market

  • 16.1. UK Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Continuous Manufacturing Market

  • 17.1. Germany Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Continuous Manufacturing Market

  • 18.1. France Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Continuous Manufacturing Market

  • 19.1. Italy Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Continuous Manufacturing Market

  • 20.1. Spain Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Continuous Manufacturing Market

  • 21.1. Eastern Europe Pharmaceutical Continuous Manufacturing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Continuous Manufacturing Market

  • 22.1. Russia Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Continuous Manufacturing Market

  • 23.1. North America Pharmaceutical Continuous Manufacturing Market Overview
  • 23.2. North America Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Continuous Manufacturing Market

  • 24.1. USA Pharmaceutical Continuous Manufacturing Market Overview
  • 24.2. USA Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Continuous Manufacturing Market

  • 25.1. Canada Pharmaceutical Continuous Manufacturing Market Overview
  • 25.2. Canada Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Continuous Manufacturing Market

  • 26.1. South America Pharmaceutical Continuous Manufacturing Market Overview
  • 26.2. South America Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Continuous Manufacturing Market

  • 27.1. Brazil Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Continuous Manufacturing Market

  • 28.1. Middle East Pharmaceutical Continuous Manufacturing Market Overview
  • 28.2. Middle East Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Continuous Manufacturing Market

  • 29.1. Africa Pharmaceutical Continuous Manufacturing Market Overview
  • 29.2. Africa Pharmaceutical Continuous Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmaceutical Continuous Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmaceutical Continuous Manufacturing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Continuous Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Continuous Manufacturing Market Competitive Landscape
  • 30.2. Pharmaceutical Continuous Manufacturing Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Robert Bosch GmbH
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Thermo Fisher Scientific Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmaceutical Continuous Manufacturing Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline Plc.
  • 31.2. Eli Lilly and Company
  • 31.3. Corning Inc.
  • 31.4. Vertex Pharmaceuticals
  • 31.5. Lonza Group Ltd.
  • 31.6. GEA Group AG
  • 31.7. Catalent Inc.
  • 31.8. Mettler Toledo
  • 31.9. Patheon
  • 31.10. Cytiva
  • 31.11. Samsung Biologics Co. Ltd.
  • 31.12. WuXi Biologics
  • 31.13. Syntegon Technology GmbH
  • 31.14. Coperion GmbH
  • 31.15. Hosokawa Micron Group

32. Global Pharmaceutical Continuous Manufacturing Market Competitive Benchmarking

33. Global Pharmaceutical Continuous Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Continuous Manufacturing Market

35. Pharmaceutical Continuous Manufacturing Market Future Outlook and Potential Analysis

  • 35.1 Pharmaceutical Continuous Manufacturing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Continuous Manufacturing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Continuous Manufacturing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer